Molecular phenotyping reveals the identity of Barrett's esophagus and its malignant transition.
Karol Nowicki-OsuchLizhe ZhuangSriganesh JammulaChristopher W BleaneyKrishnaa T A MahbubaniGinny DevonshireAnnalise Katz-SummercornNils ElingAnna Wilbrey-ClarkElo MadissoonJohn GambleMassimilliano di PietroMaria O'DonovanKerstin B MeyerKourosh Saeb ParsyAndrew D SharrocksSarah A TeichmannJohn C MarioniRebecca C FitzgeraldPublished in: Science (New York, N.Y.) (2021)
The origin of human metaplastic states and their propensity for cancer is poorly understood. Barrett's esophagus is a common metaplastic condition that increases the risk for esophageal adenocarcinoma, and its cellular origin is enigmatic. To address this, we harvested tissues spanning the gastroesophageal junction from healthy and diseased donors, including isolation of esophageal submucosal glands. A combination of single-cell transcriptomic profiling, in silico lineage tracing from methylation, open chromatin and somatic mutation analyses, and functional studies in organoid models showed that Barrett's esophagus originates from gastric cardia through c-MYC and HNF4A-driven transcriptional programs. Furthermore, our data indicate that esophageal adenocarcinoma likely arises from undifferentiated Barrett's esophagus cell types even in the absence of a pathologically identifiable metaplastic precursor, illuminating early detection strategies.
Keyphrases
- single cell
- rna seq
- high throughput
- gene expression
- squamous cell carcinoma
- transcription factor
- genome wide
- papillary thyroid
- endothelial cells
- locally advanced
- electronic health record
- dna methylation
- big data
- dna damage
- nuclear factor
- stem cells
- mesenchymal stem cells
- data analysis
- oxidative stress
- immune response
- heat shock